Author Archives: KSW

USA – FDA Warning Letter – Maribel’s Sweets, Inc.

FDA

WARNING LETTER
CMS 616288

October 25, 2021

Ms. Gracia Borjas, Production Manager

Dear Ms. Leiberman and Ms. Borjas:

The United States Food and Drug Administration (FDA) inspected your food manufacturing facility located at 38 Dobbin Street, Brooklyn, NY 11222, where you manufacture Ready-to-Eat (RTE) chocolate products (including chocolate bars, ganache, hot chocolate, and cookies), and you repack chocolate products (including hot chocolate, brownies, and caramel bonbons), from June 1 through June 17, 2021. During our inspection, FDA investigators found serious violations of the Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Human Food regulation (CGMP & PC rule), Title 21, Code of Federal Regulations, part 117 (21 CFR part 117). At the conclusion of the inspection, FDA issued an FDA Form 483, Inspectional Observations, listing the deviations found at your facility.

Based on FDA’s inspectional findings, we have determined that the RTE chocolate products manufactured in your facility are adulterated within the meaning of section 402(a)(4) of the Federal Food, Drug, and Cosmetic Act (the Act) [21 U.S.C. § 342(a)(4)] in that they were prepared, packed, or held under insanitary conditions whereby they may have become contaminated with filth or rendered injurious to health. In addition, failure of the owner, operator, or agent in charge of a covered facility to comply with the preventive controls provisions of the CGMP & PC rule (located in subparts A, C, D, E, F, and G of part 117) is prohibited by Section 301(uu) of the Act [21 USC 331(uu)]. You may find the Act and FDA’s regulations through links in FDA’s home page at http://www.fda.gov/.

We received your response, sent via email on July 6, 2021, which included a summary of corrective actions you have taken or plan to take. After reviewing the inspectional findings and your response to the observations listed in the FDA Form 483, we are issuing this letter to advise you of FDA’s concerns and provide detailed information describing the findings at your facility. We address your response below.

Hazard Analysis and Risk-Based Preventive Controls (Subpart C):

1. You did not prepare, or have prepared, and implement a food safety plan as required by 21 CFR § 117.126(a)(1). The food safety plan must be prepared, or its preparation overseen, by a preventive controls qualified individual and must include the following:

1) The written hazard analysis, as required by 21 CFR § 117.130(a)(2);
2) The written preventive controls, as required by 21 CFR § 117.135(b);
3) The written supply-chain program, as required by Subpart G;
4) The written recall plan, as required by 21 CFR § 117.139(a);
5) The written procedures for monitoring the implementation of the preventive controls, as required by 21 CFR § 117.145(a);
6) The written corrective action procedures, as required by 21 CFR § 117.150(a)(1); and
7) The written verification procedures, as required by 21 CFR § 117.165(b).

2. You did not conduct a hazard analysis to identify and evaluate known or reasonably foreseeable hazards for each type of food manufactured, processed, packed, or held at your facility to determine whether there are any hazards requiring a preventive control, as required by 21 CFR § 117.130(a). Specifically,

a. You did not identify and evaluate allergens as a known or reasonably foreseeable hazard to determine whether allergens are a hazard that requires a preventive control. Your facility receives, stores, and manufactures products that contain allergens such as wheat, milk, tree nuts (e.g., hazelnuts, almonds, and pistachios), and soy. Foods containing allergens can cause serious adverse health consequences or death to allergic individuals if they consume a food to which they are allergic. A knowledgeable person manufacturing/processing food in your circumstances would identify allergens as hazards requiring a preventive control.

b. You did not identify and evaluate bacterial pathogens, such as Salmonella, as a known or reasonably foreseeable hazard to determine whether they require a preventive control. Your facility manufactures food with tree nuts (e.g., hazelnuts, almonds, and pistachios) and various chocolates. These ingredients have been associated with pathogens such as Salmonella.

c. You did not identify and evaluate mycotoxins as a known or reasonably foreseeable hazard to determine whether they require a preventive control. Your facility manufactures/processes food with tree nuts (e.g., hazelnuts, almonds, and pistachios). These ingredients have been associated with mycotoxins such as aflatoxin.

d. You did not identify and evaluate contamination with environmental pathogens, such as Salmonella, as a known or reasonably foreseeable hazard to determine whether they require a preventive control as required by 21 CFR § 117.130(c)(1)(ii). Your facility manufactures RTE food which is exposed to the environment prior to packaging. The packaged food does not receive a lethal treatment or otherwise include a control measure (such as a formulation lethal to the pathogen) that would significantly minimize the pathogen. Note that environmental monitoring is required if contamination of an RTE food with an environmental pathogen is a hazard requiring a preventive control (see 21 CFR § 117.165(a)(3)).

3. You did not identify and implement preventive controls for any of your products to provide assurance that any hazards requiring a preventive control will be significantly minimized or prevented and the food manufactured, processed, packed, or held by your facility will not be adulterated under section 402 of the Act or misbranded under section 403(w) of the Act, as required by 21 CFR § 117.135(a)(1). Preventive controls include, as appropriate to the facility and the food, process controls, food allergen controls, sanitation controls, supply-chain controls, and a recall plan (see 21 CFR § 117.135). Preventive controls are subject to preventive control management components as appropriate to ensure the effectiveness of the preventive controls, taking into account the nature of the preventive control and its role in the facility’s food safety system (see 21 CFR § 117.140).

For example, food allergen controls include procedures, practices, and processes employed for labeling to ensure that all food allergens are included on the label and that food is protected against allergen cross-contact (see 21 CFR 117.135(c)(2)). You do not have controls in place to adequately control the hazard of undeclared allergens due to incorrect labeling, as evidenced by the following. On December 1, 2020, your facility recalled Cacao Market Cylinder Dark Chocolate Pearls due to undeclared milk on the product label. The recall was initiated after an inspection by the New York State Department of Agriculture and Markets revealed that the Cacao Market Cylinder Dark Chocolate Pearls that were repacked at your facility contained a milk ingredient but did not declare milk on the finished product label. During our inspection, you explained that you had previously produced the product at your facility without milk; however, when you began outsourcing the product from one of your suppliers and repacking the product at your facility, the outsourced product contained milk. You explained that you continued using the same label that did not declare milk. During our inspection, you stated that you hired an employee to ensure that labels are updated when needed to reflect ingredient changes; however, you have no procedures in place to ensure that any needed revisions are implemented.

Further, your facility manufactures multiple products with different allergen profiles, including products that contain tree nuts (e.g., hazelnuts) and that do not contain tree nuts on the same day and on shared equipment, which can result in allergen cross-contact without appropriate controls. You do not have controls in place to adequately control the hazard of allergen cross-contact.

Your response states that you are “developing a Food Safety Plan, including all required preventative controls” and including “a flow diagram of our process, hazard analysis for all raw materials, ingredients, processing aids, and packaging materials, hazard analysis for our production process, and the identification of any process preventative controls.” Further, you state that you are developing procedures “that outline the monitoring, record keeping, corrective action, verification, and validation of all process preventative controls.” In addition, you state that you are “reevaluating our sanitation procedures and processing schedule to allow us to better control our risk of allergen cross contamination. This will include items such as scheduling allergens to be run at the end of the production schedule and fully defined procedures on when and how to break equipment down for proper cleaning.” You state that “This will include a facility wide environmental monitoring program to verify the effectiveness of our sanitation program.” Your response does not include a timeline as to when you will have these corrective actions completed or supporting information or evidence that your facility is currently conducting these corrective actions.

Current Good Manufacturing Practice (Subpart B):

1. You did not keep buildings, fixtures, and other physical facilities in a clean and sanitary condition and in repair adequate to prevent food from becoming adulterated, as required by 21 CFR § 117.35(a). Specifically,

• The skylight, located above the tempering machine inside the processing room, had apparent loose paint hanging from its metal bars. The tempering machine contained melted dark chocolate and was kept uncovered during the entire inspection.

• The floor inside your processing room exhibited cracked, peeling surfaces.

Your response states that “Loose paint was removed from the metal bars of the skylight,” and “We are evaluating our floor and putting together a plan to repair the areas that need it the most.” However, you did not provide evidence that you have removed the loose paint from the metal bars of the skylight. Additionally, your response does not include a timeline as to when you will have the floor repaired or supporting information to demonstrate that your facility is currently working on conducting corrective actions.

2. You did not clean food contact surfaces as frequently as necessary to protect against allergen cross-contact and against contamination of food, as required by 21 CFR § 117.35(d). Specifically,

• On June 1, 2021, employees were observed transferring ganache coming out of the cooling tunnel onto previously used disposable plastic trays. These trays were not clean, as food residue was observed on the trays.
• On June 2, 2021, after cleaning was performed on the metal grid, chocolate residue was observed adhered to the metal grid extension which was reattached to the cooling tunnel that was ready for the next shift’s production.

3. You did not take adequate precautions to ensure that production procedures do not contribute to allergen cross-contact and to contamination from any source, as required by 21 CFR § 117.80(a)(4). Specifically,

• On June 1, 2021, you filled, repacked, and labeled two types of hot chocolate, one of which contains the allergen hazelnut. These two products were processed simultaneously, side by side, on the same processing table.

• On June 1, 2021, while a fan was used to cool dark chocolate-filled molds, apparent chocolate dust was observed on many surfaces inside the processing room caused by the fan blowing on the dark chocolate. These surfaces included the pipes running across the ceiling and plastic covering unused equipment. You manufacture different types of chocolate products that may contain different allergens in the same room using the same method to cool the chocolate.

• Your typical practice is to store clean chocolate bar molds on a rack protected by plastic wrap. On June 1, 2021, molds that had chocolate residue within their ridges were observed being stored on the clean mold storage rack. An employee explained that these molds were used to make milk chocolate bars and were placed on the clean rack in error. The employee added that the facility has designated molds for milk and dark chocolate bars; however, these molds are identical. The facility does not have a system in place to monitor cleaning and to differentiate between the two molds.

4. You did not take reasonable measures and precautions to ensure that all persons working in direct contact with food wash hands thoroughly (and sanitize if necessary to protect against contamination with undesirable microorganisms) before starting work, after each absence from the work station, and at any other time when the hands may have become soiled or contaminated, as required by 21 CFR § 117.10(b)(3). Specifically, on June 1, 2021, two employees were observed returning to the processing room after taking their break, and they proceeded with processing ganache without washing and sanitizing their hands.

The violations cited in this letter are not intended to be an all-inclusive list of violations that exist at your facility or in connection with your products. You are responsible for investigating and determining the causes of the violations identified above and for preventing their recurrence or the occurrence of other violations. It is your responsibility to ensure your facility complies with all requirements of federal law, including FDA regulations. You should take prompt action to correct or implement corrections to the violations cited in this letter. Failure to do so may result in legal action without further notice, including, without limitation, seizure, injunction, or administrative action for suspension of food facility registration if criteria and conditions warrant.

Please notify FDA in writing, within 15 working days of the receipt of this letter, of the specific steps you have taken to address these violations. Include an explanation of each step being taken to prevent the recurrence of violations, as well as copies of related documentation. If you believe that your products are not in violation of the Act, include your reasoning and any supporting information for our consideration. If you cannot complete addressing these violations within 15 working days, state the reason for the delay and the timeframe within which you will do so.

Section 743 of the FDCA (21 U.S.C. 379j-31) authorizes FDA to assess and collect fees to cover FDA’s costs for certain activities, including re-inspection-related costs. A re-inspection is one or more inspections conducted subsequent to an inspection that identified noncompliance materially related to a food safety requirement of the Act, specifically to determine whether compliance has been achieved. Re-inspection-related costs means all expenses, including administrative expenses, incurred in connection with FDA’s arranging, conducting, and evaluating the results of the re-inspection, assessing and collecting the re-inspection fees [21 U.S.C. 379j-31(a)(2)(B)]. For a domestic facility, FDA will assess and collect fees for re-inspection-related costs from the responsible party for the domestic facility. The inspection noted in this letter identified noncompliance materially related to a food safety requirement of the Act. Accordingly, FDA may assess fees to cover any reinspection-related costs.

Please send your reply to the Food and Drug Administration, Attention: W. Martin Rennells, Compliance Officer, One Winner’s Circle, Suite 140, Albany, NY 12205. If you have questions regarding any issues in this letter, please contact Mr. Rennells at 518-453-2314 x1038 or willliam.rennells@fda.hhs.gov.

Sincerely,
/S/

Ronald M. Pace
Program Division Director
Office of Human and Animal Food Operations –
East Division 1

France – SALTED AND SMOKED HERRING FILLETS IN COLZA OIL – Listeria monocytogenes

Gov france

Identifying information for the recalled product

  • Product category Food
  • Product sub-category Fishery and aquaculture products
  • Product brand name BAR
  • Names of models or references SALTED AND SMOKED HERRING FILLETS IN COLZA OIL 2.5 kg
  • Product identification
    GTIN Lot Dated
    3246993546003 044121/243 Use-by date 12/12/2021
  • Packaging2.5 KG BUCKET
  • Start date / End of marketing From 11/03/2021 to 11/30/2021
  • Storage temperature Product to be stored in the refrigerator
  • Health mark PL 30221802
  • Geographical sales area Whole France
  • Distributors POmona
  • List of points of saleHareng_LB_2.5kg_30.11.21.pdf

Practical information regarding the recall

  • Reason for recall Unsatisfactory analysis, presence of Listeria <10 / g
  • Risks incurred by the consumer Listeria monocytogenes (causative agent of listeriosis)

France – Reblochon Savoie Fruitier PDO – Brucella spp

Gov france

Identifying information for the recalled product

  • Product category Food
  • Product sub-category Milk and dairy products
  • Product brand name COOP VAL D’ARLY
  • Names of models or references REBLOCHON DE SAVOIEE FRUITIER AOP
  • Product identification
    GTIN Lot Dated
    3489450003200 Lots 312013 and 311932 Use-by date 12/07/2021
  • Packaging450grs
  • Start date / End of marketing From 10/21/2021 to 11/18/2021
  • Storage temperature Product to be stored in the refrigerator
  • Geographical sales area Whole France
  • Distributors promocash

Practical information regarding the recall

  • Reason for recall SUSPICION OF CONTAMINATION OF PRODUCTS BY BRUCELLA MELITENSIS
  • Risks incurred by the consumer Brucella spp (causative agent of brucellosis)

India – 4 more norovirus cases in Thrissur

The Hindu

Norovirus Food Safety kswfoodworld

Four more cases of norovirus were reported from a college in Thrissur on Tuesday. The infection was reported in four day scholars of the college.

Though 57 cases have been reported from the college earlier, they were in college hostels. The Health Department has asked the college authorities to make the classes online.

According to preliminary investigation, the infection spread from the drinking water distributed in the hostel.

Germany – E. coli in lamb and flour prompts warning in Germany

Food Safety News

Findings of E. coli in lamb and flour has triggered a warning from German authorities.

Basic rules of kitchen hygiene, such as using different cutting boards for raw meat and vegetables, should be followed. Proper cooking is one of the best ways to avoid food poisoning from E. coli.

As part of zoonosis monitoring in Germany in 2020, Shiga toxin-producing E. coli (STEC) were detected in 50 of 380 samples of fresh lamb.

Lamb from Germany was significantly more often STEC-positive than that from other countries with 36 of 190 samples positive compared to 12 of 177.

Consumers, especially small children, the elderly, the immunocompromised and pregnant women, should only consume lamb that has been well cooked, advised the Federal Office for Consumer Protection and Food Safety (BVL).

“An infection with STEC should not be underestimated. In children in particular, it can lead to the development of hemolytic uremic syndrome (HUS), which is often associated with acute kidney failure,” said Friedel Cramer, BVL president.

STEC was detected in 22 of 242 samples of wheat flour from milling operations. Consumers can minimize this risk by not eating raw dough, cake batter or other foods containing raw flour. E. coli was also found in six of 318 samples of raw milk soft cheese sold at retail, from wholesale and at import points.

In total, 94 isolates belonged to 28 different O serogroups with O146 as the most common while O157 was not detected.

France – Butter, Faisselle – Salmonella

Gov france

Identifying information for the recalled product

  • Product category Food
  • Product sub-category Milk and dairy products
  • Product brand name No Brand
  • Names of models or references Thursday 11/18: faisselles DLC 11/25 Friday 11/19: soft butters, salted butters DLC 10/12
  • Product identification
    Lot Dated
    Soft butters, salted butters made on Friday 11/19: DLC 10/12 Use-by date 12/10/2021
    Faisselles manufactured on 25/11: DLC 10/12 Use-by date 25/11/2021
  • Start date / End of marketing From 11/19/2021 to 11/26/2021
  • Storage temperature Product to be stored in the refrigerator
  • Geographical sales area30 km radius
  • Distributors Villeneuve farm – rue de la plaine-41000 Saint Denis sur Loire

Practical information regarding the recall

  • Reason for recall GAEC Daudin Fils is now withdrawing from the sale of the following products following the suspicion of the presence of salmonella.
  • Risks incurred by the consumer Salmonella spp (causative agent of salmonellosis)

UK – Morrisons Tackling Campylobacter

Morrisons

Since 2013 we have been working hard to reduce Campylobacter levels in fresh chicken. We have introduced a Campylobacter reduction plan which has shown significant improvements year on year.

Our results for the 2nd Quarter of 2021 (April to June) are as follows:

  • 0.8% of our chickens have the higher levels of contamination compared to the FSA retail target of 7% from a sample of 120 chickens tested.

Our results now for the last 26 consecutive quarters have been below the 7% FSA retail target.

The facts:

• Campylobacter is a common bacteria which causes food poisoning which can be found on fresh chicken.
• Campylobacter is destroyed if chicken is cooked thoroughly.
• As a bacteria, campylobacter can be transferred on to any surface that raw chicken contacts.
• Food Standards Agency (FSA) advice is Do Not Wash raw chicken.

Click here for a quick guide from the FSA about Campylobacter

How you can prevent it:

We understand that campylobacter can be a concern when it comes to handling fresh chicken.

However there are 4 simple steps you can take at home to minimise the risk of food poisoning:

  • Step 1 – Cover and chill raw poultry at the bottom of the fridge
  • Step 2 – Do not wash poultry
  • Step 3 – Wash hands and utensils after handling raw poultry
  • Step 4 – Ensure poultry is thoroughly cooked

What Morrisons have achieved:

  • A long term reduction of campylobacter levels from 2014 to 2021.
  • We have worked with our suppliers and implemented a Campylobacter Action Plan, which has successfully reduced campylobacter levels on fresh chicken.
  • We have established our own monitoring program; our test results show levels of campylobacter are now consistnently below the FSA 7% target (for the last 26 quarters).

image4mr2e.png

What’s next?

While the results of our reduction programme are extremely encouraging, we are not complacent and we will continue to work closely with all areas of the industry to continually find areas to improve.

UK – Co-op Tackling Campylobacter

COOP

Food safety is an absolute priority for Co-op and we are determined to tackle Campylobacter. How will we do this? By working together with our farmers and suppliers to reduce the incidence of Campylobacter. We have been keen supporters of the initiatives the FSA (Food Standards Agency) have driven to combat Campylobacter.

Industry Campaign

Co-op were one of the first retailers to sign up to be part of the Foods Standards Agency’s ‘Acting on Campylobacter Together’ (ACT) campaign. The joint aim was to rapidly introduce and share the best workable and available technologies and techniques in food production and across the supply chain.

The FSA started the Campylobacter retail survey in 2014 sampling from nine retailers and publishing results showing % of chickens with incidence of Campylobacter at highest contamination levels (>1000cfu/g) . By the beginning of 2017 the overall results were showing a significant reduction in the percentage of chickens with high levels of Campylobacter from 20.3% (July 2014 – February 2015) to 7% with highest contamination levels (August – December 2016).

Heather Hancock, Chairman of the Food Standards Agency, said:

“The challenge we set of reducing the number of people who get ill from campylobacter has been achieved. In the absence of any other clear indicators, we can reasonably say that the work that we and the food industry have done from farm to fork has given us this really positive result for public health.

“This has been achieved by working with the industry to tackle this difficult problem and raising consumer awareness. We commend the efforts of the larger retailers and the major processing plants who supply them, all of which have shown significant improvement and many have achieved the target we set to reduce the highest levels of campylobacter. They have invested a lot of effort and money into interventions to tackle the problem.

Extract taken from the Campylobacter News Story 13.03.17

Our Results

From January 2017, food retailers have published our own Campylobacter test results for fresh chicken, in collaboration with the open data scheme on Campylobacter with the Food Standards Agency.

Campylobacter results Q3 2021

UK – J Sainsbury Tackling Campylobacter

Sainsburys

12 January 2021

Our customers’ health and safety is of paramount importance to us. Working closely with our suppliers and farmers, we are committed to ensuring that levels of Campylobacter on our fresh chicken are kept as low as possible

Campylobacter is commonly found on chicken and can cause food poisoning if chicken isn’t prepared and cooked properly. It’s not yet possible to eliminate it from raw chicken, but we have been working hard to reduce levels.

From farm to fork

Smiley face

With our suppliers, we’ve been busy finding ways to tackle Campylobacter at every step of the food chain. This starts on the farm by trying to stop Campylobacter from colonising flocks, introducing novel thermal treatments in the factory as well as new convenient roast in the bag packaging.

Like other raw meats, chicken still needs to be handled with care, but lower levels of Campylobacter means improved safety for our customers when they are preparing chicken at home. We were the first retailer to include food safety advice on our products.

How are we doing?

We test nearly a thousand chickens a year to check on how we are doing, and we continue to make progress. We’ve achieved a target that was set by the UK Food Standards Agency (FSA), but are committed to continue making further improvements wherever we can. To do this, we need to find new solutions through further research and trials, working closely with our suppliers.

UK – M&S Campylobacter Results Q2 – 2021

Click to access campylobacter-q2-2021.pdf